CFAP97: A Potential Drug Target and Biomarker (G57587)

Target Name: CFAP97

NCBI ID: G57587

CFAP97

CFAP97: A Potential Drug Target and Biomarker

Introduction

Cilia and flagella are structures found in the cytoskeleton of eukaryotic cells that are essential for cell movement and proper functioning. Cilia help to keep the cell in a continuous state of motion, which is critical for various cellular processes such as phagocytes phagocytosis and secretory functions . Flagella, on the other hand, are the molecular motors that drive prokaryotic flagella to generate movement. Both cilia and flagella are critical for the proper functioning of eukaryotic cells, and defects in their structure or function can lead to various diseases.

CFAP97, a protein that is found in the cytoskeleton of eukaryotic cells, has been identified as a potential drug target and biomarker. CFAP97 is a 25 kDa protein that is composed of 214 amino acids. It is localized to the endoplasmic reticulum and is involved in the formation of cilia. CFAP97 is a critical regulator of the formation and maintenance of cilia, and its dysfunction has been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Potential Drug Target

CFAP97 has been identified as a potential drug target due to its involvement in the regulation of cilia formation and its association with various diseases. One of the main reasons for its potential as a drug target is its location in the endoplasmic reticulum, which is a membrane -bound organelle that is responsible for the synthesis, processing, and storage of proteins. Since CFAP97 is a protein that is primarily localized to the endoplasmic reticulum, it is highly vulnerable to drug-induced changes, including those that can lead to its degradation or inhibition of its function.

CFAP97 has also been shown to play a role in the regulation of cilia formation, which is critical for the proper functioning of many cellular processes. Cilia are specialized structures that are found in the cytoskeleton of eukaryotic cells and are responsible for the continuous movement of cells . They are essential for the proper delivery of various cellular molecules, including viruses and bacteria, and for the removal of waste products from the cell. CFAP97 is involved in the regulation of cilia formation by promoting the negative regulation of the cytoskeleton, which is critical for the formation and maintenance of cilia.

CFAP97 is also associated with various diseases, including cancer and neurodegenerative diseases. Its dysfunction has been linked to the development of various diseases, including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to be caused by the dysfunction of CFAP97.

Biomarker

CFAP97 has also been identified as a potential biomarker for several diseases. Its dysfunction has been linked to the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Its expression has been shown to be increased in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that CFAP97 may be a useful biomarker for these conditions.

CFAP97 has also been shown to be involved in the regulation of several cellular processes, including cell adhesion, migration, and invasion. Its dysfunction has been linked to the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that CFAP97 may be a useful target for the development of new therapeutic approaches for these conditions.

Conclusion

CFAP97 is a protein that is

Protein Name: Cilia And Flagella Associated Protein 97

The "CFAP97 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP97 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets